BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7814291)

  • 1. Antiviral activity of famciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.
    Ashton RJ; Abbott KH; Smith GM; Sutton D
    J Antimicrob Chemother; 1994 Aug; 34(2):287-90. PubMed ID: 7814291
    [No Abstract]   [Full Text] [Related]  

  • 2. Famciclovir/penciclovir.
    Sacks SL; Wilson B
    Adv Exp Med Biol; 1999; 458():135-47. PubMed ID: 10549386
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency.
    Thackray AM; Field HJ
    J Infect Dis; 1996 Feb; 173(2):291-9. PubMed ID: 8568288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice: how dissimilar are study results?
    Thackray AM; Field HJ
    J Infect Dis; 2000 Apr; 181(4):1517-8. PubMed ID: 10762588
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model.
    Field HJ; Tewari D; Sutton D; Thackray AM
    Antimicrob Agents Chemother; 1995 May; 39(5):1114-9. PubMed ID: 7625798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early therapy with valaciclovir or famciclovir reduces but does not abrogate herpes simplex virus neuronal latency.
    Field HJ; Thackray AM
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):461-70. PubMed ID: 10772727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
    Romanowski B; Aoki FY; Martel AY; Lavender EA; Parsons JE; Saltzman RL
    AIDS; 2000 Jun; 14(9):1211-7. PubMed ID: 10894286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Famciclovir safe and effective for herpes.
    AIDS Patient Care STDS; 1997 Oct; 11(5):375. PubMed ID: 11361826
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology of new antiherpes agents: famciclovir and valacyclovir.
    Stein GE
    J Am Pharm Assoc (Wash); 1997; NS37(2):157-63. PubMed ID: 9069689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successors to acyclovir.
    Easterbrook P; Wood MJ
    J Antimicrob Chemother; 1994 Sep; 34(3):307-11. PubMed ID: 7829405
    [No Abstract]   [Full Text] [Related]  

  • 12. Famciclovir or valaciclovir in the management of herpes simplex and varicella zoster infections: an attitudinal survey of clinician perceptions of differential activity.
    Smith DE; Gold J
    Sex Health; 2007 Jun; 4(2):141-2. PubMed ID: 17524295
    [No Abstract]   [Full Text] [Related]  

  • 13. Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study.
    Thackray AM; Field HJ
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1555-62. PubMed ID: 9660982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus infection.
    Whitley RJ
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):6-11. PubMed ID: 12118847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of famciclovir and valaciclovir in the treatment of viral keratitis.
    Gatchel S
    Clin Infect Dis; 1996 May; 22(5):886. PubMed ID: 8722973
    [No Abstract]   [Full Text] [Related]  

  • 16. [Perspectives for the treatment and prevention of herpes simplex infections].
    Snoeck R
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):662-5. PubMed ID: 12122338
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in the treatment of herpesvirus infection: the role of famciclovir.
    Tyring SK
    Clin Ther; 1998; 20(4):661-70. PubMed ID: 9737826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.
    Biswas S; Jennens L; Field HJ
    Antiviral Res; 2007 Jul; 75(1):30-5. PubMed ID: 17175035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment.
    Thackray AM; Field HJ
    J Gen Virol; 2000 Oct; 81(Pt 10):2385-2396. PubMed ID: 10993926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WITHDRAWN: Antiviral treatment for Bell's palsy (idiopathic facial paralysis).
    Gagyor I; Madhok VB; Daly F; Somasundara D; Sullivan M; Gammie F; Sullivan F
    Cochrane Database Syst Rev; 2015 Sep; (9):CD001869. PubMed ID: 26343420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.